Hear From Your Peers! Neurolens Roundtable 2023
Posted on
Hear from your peers: Dr. Brenda Montecalvo, Dr. Paul Karpecki, Dr. Ray Corbin-Simon, Dr. Amanda Nanasy, and Dr. Carol...
20/20 Pro to Pro Series
Posted on
PART ONE: 20/20 Pro to Pro Series According to The American Board of Optometry, Americans are on their computers and...
Neurolens Raises $67 Million from MVM Partners, Falcon Vision/KKR, Marshall Wace & Existing Investors
Posted on
Investment will be used to develop new products and drive adoption. DALLAS, Texas, September 12, 2022 – Neurolens, a...
Neurolens Top 30 Healthcare Company on Inc. 5000 2022 List
Posted on
Neurolens 28th Fastest Growing Healthcare Company on 2022 Inc. 5000 List. Overall, Neurolens receives ranking of 1,773...
Neurolenses have significant impact on reading speed.
Posted on
New parallel arm study results have implications for productivity and learning. Coppell, Texas, August 8, 2022 – As...
Neurolens Partners With The University Of Montreal’s Clinique Universitaire De La Vision
Posted on
Joint projects will fuel Neurolens clinical foundation and future product innovations. Coppell, Texas, March 7, 2022 –